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The Tsk2/þ Mouse Fibrotic Phenotype Is Due to a
Gain-of-Function Mutation in the PIIINP Segment of
the Col3a1 Gene
Kristen B. Long1, Zhenghui Li2, Chelsea M. Burgwin1, Susanna G. Choe2, Viktor Martyanov2,
Sihem Sassi-Gaha1, Josh P. Earl3, Rory A. Eutsey3, Azad Ahmed3, Garth D. Ehrlich3, Carol M. Artlett1,
Michael L. Whitfield2 and Elizabeth P. Blankenhorn1
Systemic sclerosis (SSc) is a polygenic, autoimmune disorder of unknown etiology, characterized by the excessive
accumulation of extracellular matrix (ECM) proteins, vascular alterations, and autoantibodies. The tight skin
(Tsk)2/þ mouse model of SSc demonstrates signs similar to SSc including tight skin and excessive deposition of
dermal ECM proteins. By linkage analysis, we mapped the Tsk2 gene mutation too3 megabases on chromosome
1. We performed both RNA sequencing of skin transcripts and genome capture DNA sequencing of the region
spanning this interval in Tsk2/þ and wild-type littermates. A missense point mutation in the procollagen III
amino terminal propeptide segment (PIIINP) of collagen, type III, alpha 1 (Col3a1) was found to be the best
candidate for Tsk2; hence, both in vivo and in vitro genetic complementation tests were used to prove that this
Col3a1 mutation is the Tsk2 gene. All previously documented mutations in the human Col3a1 gene are associated
with the Ehlers–Danlos syndrome, a connective tissue disorder that leads to a defect in type III collagen synthesis.
To our knowledge, the Tsk2 point mutation is the first documented gain-of-function mutation associated with
Col3a1, which leads instead to fibrosis. This discovery provides insight into the mechanism of skin fibrosis
manifested by Tsk2/þ mice.
Journal of Investigative Dermatology (2015) 135, 718–727; doi:10.1038/jid.2014.455; published online 20 November 2014
INTRODUCTION
There are multiple animal models of systemic sclerosis (SSc)
(Artlett, 2010); yet, none mimics all facets of SSc disease. Of
the genetic models, the cause of disease in tight-skin 1 (Tsk1/þ )
mice is known to be a tandem duplication in the fibrillin-1
(Fbn1) gene (Siracusa et al., 1996). Other models of SSc have
employed mice with individual gene deficiencies or
overexpression including Fos-related antigen-2 (Fra2; Maurer
et al., 2009), endothelin-1 (Edn1; Hocher et al., 2000; Richard
et al., 2008), and Friend leukemia integration 1 transcription
factor (Fli1; Asano et al., 2010), which have proven useful for
understanding the contribution of these proteins to the
vasculopathy and/or lung fibrosis seen in SSc. Nongenetic
models of SSc include the bleomycin-induced scleroderma
model (Yamamoto et al., 1999), which has been used to study
many of the initiating events involved in fibrosis.
The Tsk2/þ mouse was first described in 1986, when an
offspring of a 101/H mouse exposed to the mutagenic agent
ethylnitrosourea was noted to have tight skin in the
interscapular region (Peters and Ball, 1986). The mutagenized
gene causing SSc-like signs in Tsk2/þ mice was reported to be
located on chromosome 1 between 42.5 and 52.5 megabases
(Mb; Christner et al., 1996); however, the genetic defect was
never identified. Similar to Tsk1, Tsk2 SSc-like traits are highly
penetrant in Tsk2/þ heterozygotes and it is homozygous
embryonic lethal. Tsk2/þ mice have many features of human
disease including tight skin, dysregulated dermal extracellular
matrix (ECM) deposition, and evidence of an autoimmune
response (Christner et al., 1995; Gentiletti et al., 2005).
Herein, we report the positional cloning and identity of the
Tsk2 gene. We have discovered that Tsk2/þ mice carry a
deleterious gain-of-function missense mutation in Col3a1
(collagen, type III, alpha 1), which exchanges a cysteine for
serine in the N-terminal propeptide, procollagen III amino
terminal propeptide segment (PIIINP). The Tsk2/þ mouse
affords a unique opportunity to examine the pathways leading
to the multiple clinical parameters of fibrotic disease from
birth onward.
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RESULTS
Linkage and sequencing studies reveal a SNP mutation in Col3a1
Identification of the Tsk2 gene was initiated with further
mapping of the Tsk2 interval by genotyping backcross progeny
of Tsk2/þ mice bred to C57Bl/6 (B6) mice. Littermate mice
were genotyped for informative microsatellites (D1Mit233,
D1Mit235, a microsatellite in Gls, and D1Mit18) and single-
nucleotide polymorphism (SNP) genotyping assays used for
additional markers. Multiple recombinants were recovered
that mapped the interval to between 42.53 and 52.22Mb on
chromosome 1. Recombinants were bred and then back-
crossed to a consomic B6.chr 1-A/J mouse to fine map the
region by SNP typing, as A/J mice bear many known SNPs
compared with B6 mice. Additional recombinants were
recovered and new SNPs from the sequencing projects (see
below) were used to narrow the Tsk2 interval to between
44.67 and 46.27Mb (Figure 1a), representing a 43-fold
reduction in the size of the interval bearing 101/H genomic
DNA and Tsk2. There are six known genes in this interval
(Figure 1b).
To identify the mutation underlying Tsk2, we employed
both RNA sequencing (RNA-Seq) and genome capture
sequencing of the reduced genomic interval. Sequence reads
were aligned to the MM9 reference genome (B6) and analyzed
for polymorphisms in the Tsk2 interval. There were 265 SNPs
found in both wild type (WT) and Tsk2/þ littermates that
represent differences between the reference B6 genome and
the 101/H background; these were excluded from further
study. Thirteen SNPs were found in all four Tsk2/þ mice
analyzed; 10 of these SNPs were also found to be in liver RNA
from 101/H strain or in other non-fibrotic mouse strains (http://
phenome.jax.org/) and were also ruled out as candidates for
Tsk2 (Table 1). The remaining three SNPs were heterozygous
and confirmed to be only in Tsk2/þ mice. One of these, in a
Gulp1 intron, proved useful as an additional marker that
resides outside the supported linkage interval for Tsk2/þ on
the proximal end in an informative recombinant mouse
(Figure 1a). A second SNP was also found in an intron of
Gulp1. The RNA-Seq data did not identify any splicing
defects in Gulp1 mRNA in the Tsk2/þ mice (Supplementary
Figure S1 online), indicating that this SNP does not change
Gulp1 mRNA splicing, and its gene expression in the skin is
unchanged (Figure 2). Thus, the intronic SNP in Gulp1 is
unlikely to have a role in the tight skin phenotype. The
remaining mutation was in Col3a1 that results in a T-to-A
transversion at Chr1:45,378,353, causing a Cys-Ser amino
acid change in the PIIINP, a natural cleavage product of
COL3A1. The mutant protein is designated COL3A1Tsk2
(C33S).
We calculated the reads per kilobase per million mapped
reads for each gene and found that of the genes in the reduced
genomic interval, Col3a1 shows the highest absolute expres-
sion level with all other genes showing negligible expression
levels. RNA-Seq results indicate that there is a trend toward
higher Col3a1 mRNA abundance in 4-week-old Tsk2/þ skin
samples compared with WT littermates (Figure 2a and b). The
Col3a1Tsk2 (C33S) mutation is unlikely to change the expres-
sion levels of the Col3a1 mRNA directly but will result in
a mutated protein that is deposited in the ECM along with
the WT protein in mixed heterotrimers, and could result in
activation of pathways that impinge on Col3a1, such as
transforming growth factor-b (Sargent, et al., submitted).
Because Tsk2/þ (affected) mice are heterozygous, the
Col3a1Tsk2 (C33S) mutation should account for 50% of the
reads assuming equal expression from each allele. We
calculated the read count from the RNA-Seq data for the
reference and alternate alleles for Col3a1 at Chr1:45,378,353.
In WT mice, we find that all reads (492 total) contain the
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Figure 1. Tsk2 lies between and not including 44.67–46.27 Mb on chromosome 1. (a) The Tsk2 interval was narrowed by genotyping backcrossed mice on the B6
and B6.chr 1-A/J backgrounds. Black bars (101/H) depict the original parental strain, bearing Tsk2. White bars depict the B6 genome. Recombinants A–G bear
additional recombination sites. The phenotypes are tight (T—Tsk2/þ ) or loose (L—WT). (b) With the use of additional markers (arrows, see text), the current
interval comprises Col3a1, Col5a2, Wdr75, Slc40a1, part of Gulp1, and part of Dnahc7b; the five latter genes do not have coding region mutations. The elements
of the Gulp1 gene above 44.67Mb are excluded by the recombination in mouse F, and Dnahc7b below 46.27 is excluded by mouse G. B6, C57Bl/6; Col3a1,
collagen, type III, alpha 1; Mb, megabases; SNP, single-nucleotide polymorphism; Tsk, tight skin; WT, wild type.
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reference T allele, whereas in Tsk2/þ , we find that 48% of
reads (273/564 total reads) contain the WT (T) allele and 52%
(291/564 total reads) contain the Col3a1Tsk2 (C33S) allele (T -
4 A; Figure 2c). As a comparison, we show that the intronic
Gulp1 SNP at Chr1:44,833,682 has significantly lower read
coverage consistent with its intronic location (11-fold cover-
age in Tsk2/þ and 2-fold coverage in WT). The intronic
Gulp1 SNP also shows a distribution of reads consistent with
heterozygosity in Tsk2/þ and with homozygosity in WT
(Figure 2d). These findings show that the Col3a1Tsk2 (C33S)
locus is heterozygous as expected for the Tsk2 mutation in
these animals, and expression occurs equally from each of the
alleles.
Because RNA-Seq only captures variation in the transcribed
regions of the genome, and thus might miss an important
genomic feature that is unique to Tsk2, we sequenced
captured genomic DNA samples corresponding to the mini-
mal linkage region from B6.Tsk2/þ heterozygotes and 101/H
homozygous parental strain mice. Multiple DNA differences
between the Tsk2/þ mouse and its parental 101/H strain were
detected. A majority of the differences observed were
accounted for by non-chromosome 1 repetitive DNA
sequences such as LINE, SINE, and retroviral elements con-
tained within the Tsk2 interval on chromosome 1. After
filtering repetitive elements from the comparison, there were
six single-copy DNA sequence differences, of which three
were confirmed to be Tsk2/þ specific (Table 1). Among these,
there is a SNP that proved useful in demarcating the distal end
of the Tsk2 linkage interval (Chr1:46,268,651; Table 1 and
Figure 1), as it was outside the linkage interval. This allowed
us to eliminate the only other gene expressed at an appreci-
able level in the broader interval, Slc39a10. In addition, the
GULP1 intronic SNP was confirmed and another SNP in an
intron of Col5a2 was observed. Both these latter SNPs are
deemed unrelated to the phenotype, again because of their
low overall expression and the lack of any influence on
splicing or expression in the RNA-Seq results (Figure 2a and b;
Supplementary Figure S1 online). Most importantly,
however, the heterozygous T-to-A transversion in Col3A1 at
Chr1:45,378,353 was observed in the genomic sequence
comparison and was identical to the mutation identified by
RNA-Seq. There were no additional variants that could be
Table 1. Nucleotide changes between Tsk2/þ mice and 101/H or B6 mice
Nucleotide position
on
Chr 1 (MM9)
Genotype
of Tsk2/þ
Genotype
of B6
Genotype
of 101/H
Present in
other
strains?
Potential
candidate for Tsk2?
Gene or
mRNA containing
substitution
SNP found by RNA-Seq
44,675,490 A T T No No, outside interval Gulp1 intron
44,833,682* C T T No Yes Gulp1 Intron
45,378,353* A T T No Yes Col3a1 exon (C33S)
45,432,389 C G ND Yes No Col5a2 3’UTR
45,441,243 C A C No No, in 101/H Col5a2 intron
45,860,529 G A G Yes No Wdr75 intron
45,874,790 T C T Yes No Wdr75 intron
45,875,728 C T C Yes No Wdr75 exon
45,880,257 CG AC CG No No, in 101/H Wdr75 exon
46,872,610 T G ND Yes No Slc39a10 intron
46,874,711 C T C Yes No Slc39a10 intron
46,939,340 T C T Yes No BC040767 intron
46,939,624 A G ND Yes No BC040767 intron
SNP found by Genome Capture Sequencing (454)
44,833,682* C T T No Yes Gulp1 intron
45,378,353* A T T No YES Col3a1 exon (C33S)
45,465,923 A T T No YES Col5a2 intron
46,124,856 A G A Yes No Dnahc76 intron
46,124,857 A C T Yes No Dnahc76 intron
46,268,651 C T T No No, outside interval Dnahc76 intron
Abbreviations: B6, C57Bl/6; Chr, chromosome; Col3a1, collagen, type III, alpha 1; ND,not determined; RNA-Seq, RNA sequencing; SNP, single-nucleotide
polymorphism; Tsk, tight skin.
All single-copy nucleotide changes found by RNA-Seq or 454 sequencing were checked for their presence in other non-fibrotic strains (http://phenome.jax.org/)
or individually verified by a phototyping assay (Bunce et al., 1995) and/or resequencing to confirm the single-nucleotide change. SNPs that were ruled out by
one of these assays are considered not to be potential candidates for Tsk2. When known, genotypes shown for 101/H are from RNA-Seq, 454 sequencing, or
phototyping. *, Seen in both assays.
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validated on the Tsk2 chromosome withinB535,000 nucleo-
tides proximal to the transcription start site of Col3a1 gene or
closer than 59,732 nucleotides distal of the end of the Col3a1
30 untranslated region (UTR). Selective resequencing of the
30UTR likewise revealed no differences between Tsk2 and
101/H (not shown). Thus, this non-synonymous coding muta-
tion is most likely to be Tsk2 by genomic assessment, as well
as by RNA-Seq.
Mice bearing Col3a1Tsk2 and Col3a1KO are not viable
To prove that Tsk2 is a single-nucleotide change in the Col3A1
coding region required a separate genetic test. Both Tsk2/Tsk2
(Peters and Ball, 1986) and Col3a1-knockout (KO) (Liu et al.,
1997) homozygotes exhibit embryonic lethality, which is also
seen in our mouse colony (Table 2). We therefore designed a
genetic complementation test to determine whether
Col3a1Tsk2 (from Tsk2 mice) could complement and rescue
the null allele for Col3a1. Conversely, this same cross would
determine whether any other gene in the Col3a1-homozygous
KO could serve to complement the Tsk2 mutation.
Tsk2/þ Col3a1-/þ mice were bred together, and 37
progeny mice (Table 2) were genotyped. If Col3a1Tsk2
(C33S) can complement the Col3a1-KO, then we would
expect to find 9 or 10 Col3a1Tsk2/Col3a1-KO compound
heterozygotes. In fact, no viable compound heterozygotes
were born (Table 2, Supplementary Figure S2 online). The
hybrid bearing Tsk2/Col3a1-null chromosomes was not viable
because the Tsk2 gene on the Tsk2-bearing chromosome
cannot ‘‘complement’’ (rescue) the loss of the Col3a1 gene
on the Col3a1-KO chromosome. It bears only the allele of
Col3a1Tsk2 at the Col3a1 locus, which is insufficient to
provide a functional COL3A1 protein that is missing in the
Col3a1-KO. The Col3a1-null chromosome likewise cannot
complement the Tsk2 mutation: the remaining genes on the
Col3a1-KO chromosome cannot prevent the death of (cannot
‘‘complement’’) mice bearing the Tsk2 chromosome, whereas
hybrids carrying Tsk2/Col3a1-WT alleles are alive but fibrotic.
In fact, having the Tsk2 mutation is more damaging than not
expressing COL3A1 at all, because, although a few Col3a1-
KO homozygotes make it to birth, Tsk2/Tsk2 homozygotes
(and Tsk2/Col3a1-KO) never do, and, whereas Col3a1/Tsk2
mice are viable but small in stature and fibrotic, Col3a1 /þ
heterozygotes are normal. Therefore, the mutation in Tsk2/þ
mice lies within Col3a1 and, when homozygous, is substan-
tially more deleterious compared with a complete genetic
deficiency of COL3A1.
Col3a1Tsk2 induces increased COL1A1 and ECM production
in vitro
Because the compound heterozygous animals do not survive
to accumulate fibrotic levels of ECM, a direct in vivo test for
fibrosis is impossible; thus, we performed an ‘‘in vitro com-
plementation’’ test, wherein we transfected mutant or WT
Col3a1 complementary DNA (cDNA) into Col3a1-KO fibro-
blasts, harvested from a Col3a1-KO/KO homozygote at birth.
Using the production of COL1A1 as a measure of fibrosis
800
600
400
200
100
50
W
T 
(10
)
W
T 
(12
)
Ts
k2
 / 
+ 
(11
)
Ts
k2
 / 
+ 
(13
)
Ts
k2
 / 
+ 
(14
)
Ts
k2
 / 
+ 
(16
)
RPKM/100
0.
0
2.
3
4.
7
7.
0
0
Gene
291;52%
Tsk2/+ WT
REF(T)
ALT(A)
COL3A1 (Chr1: 45,378,353) GULP1 (Chr1: 44,833,682)
REF(T)
ALT(A)
REF(T)
ALT(A)
REF(T)
ALT(A)
Tsk2/+ WT
273;48%
492; 100%
6; 55%
5; 45%
2; 100%
Genes in Tsk2 interval
WT
TSK2
R
N
AS
eq
 e
xp
re
ss
io
n 
le
ve
l
Gu
lp1
Co
l3A
1
Co
l5a
2
Dn
ah
c7
b
Slc
40
a1
Slc
39
a1
0
Wd
r75
Gulp1
Col3a1
Col5a2
Wdr75
Slc40a1
Dnahc7b
Slc39a10
Figure 2. Col3a1 is the only interval gene expressed at high levels in the skin of Tsk2/þ mice. (a) This graph shows gene expression for the seven Tsk2 interval
genes, as determined from the RNA-Seq abundance results. (b) Heat map for seven Tsk2 interval genes detected as transcripts in RNA-Seq. (c, d) Distribution of
nucleotide calls in heterozygous Tsk2/þ and homozygous WT mice for Col3a1 and Gulp1. Col3a1, collagen, type III, alpha 1; RNA-Seq, RNA sequencing; Tsk,
tight skin; WT, wild type.
KB Long et al.
Mutation in Col3a1 Causes Fibrosis in Tsk2/þ Mice
www.jidonline.org 721
(shown to be expressed at high levels in Tsk2/þ skin and used
as a marker of fibrosis (Barisic-Dujmovic et al., 2008;
Christner et al., 1998)), we assessed both protein and mRNA
levels in fibroblasts that received DNA from a plasmid
containing a single allele of a single Col3a1 gene. In three
independent experiments, COL1A1 protein was significantly
elevated after 48 hours of transfection with Col3a1Tsk2 relative
to transfection with Col3a1WT (Figure 3a); mRNA for Col1a1
was likewise increased in cells transfected with mutant
Col3a1Tsk2 cDNA (Figure 3b). Transfection efficiencies were
equal in each of the experiments (Figure 3c).
Given the observation that the production of a major
indicator of fibrosis, COL1A1, is increased by the transfection
of the Col3a1Tsk2 gene, we assessed the impact of the mutant
gene genome-wide. RNA from the Col3a1Tsk2 and Col3a1WT
transfected Col3a1-KO fibroblasts and from 4-week-old Tsk2/þ
and WT littermate skin was analyzed by DNA microarray.
Differentially expressed pathways between the two transfec-
tions were determined by Gene Set Enrichment Analysis
(GSEA). Transfection of Col3a1Tsk2 results in significant
enrichment of genes associated with fibrotic Gene Ontology
terms including basement membrane, extracellular matrix,
integrin binding, and transmembrane receptor protein kinase
activity (Figure 3d; GSEA FDRo5%). The biological processes
observed in the skin of four 4-week-old female Tsk2/þ mice
relative to WT littermates also show increases in genes
associated with Gene Ontology terms extracellular matrix,
integrin binding, and basal lamina (ZL, CB, KBL, CMA, EPB,
MLW, manuscript in preparation). The genes that significantly
contributed to the GSEA pathway enrichment in the trans-
fected fibroblasts were extracted from microarray data of the
transfections, as well as from female Tsk2/þ and WT skin at 4
weeks of age (Figure 3e and f), and were elevated both in the
fibroblasts transfected with Col3a1Tsk2 and in Tsk2/þ mouse
skin. These include those genes typically associated with
fibrosis including CTGF, THY1, FBN1, the collagens, laminins,
TGFB1, TGFBR1, ADAMTS family genes, and MMP11. In
addition, there was upregulation in Col3a1Tsk2-transfected
fibroblasts and Tsk2/þ skin RNA of the vascular endothelial
growth factor receptors FLT1 and FLT4, as well as genes
associated with platelet-derived growth factor signaling
(PDGFRB and PDGFRL; Figure 3f). These data indicate that
expression of the Col3a1Tsk2 gene alone can induce a
substantial fibrotic gene expression program.
Taken together, this means that Col3a1 and Tsk2 are almost
certainly one and the same gene. Col3a1Tsk2 (C33S) is there-
fore deemed a deleterious gain-of-function allele of Col3a1,
and the Col3a1-KO is a classical loss-of-function allele. Mice
thus need at least one copy of a functional, normal Col3a1
gene.
Tsk2/þ mice have increased dermal COL3A1 protein
accumulation
The behavior of Col3a1 in Tsk2/þ mice could reveal the
mechanism by which this mutation causes very substantial
ECM fibrosis and very tight skin. We measured the level of
COL3A1 protein by histological examinations of Tsk2/þ and
WT littermate skin. Reticular fibers are composed primarily of
COL3A1 and are a structural element in the skin, found in the
panniculus carnosus and in the dermis. COL3A1 expression in
the skin from 2-week-old mice is high and declines after birth
in WT littermates but does not decline in the Tsk2/þ mice
(Figure 4a). As Tsk2/þ mice age, the reticular fibers thicken
and become more pronounced compared with their WT
littermates reflecting the accumulation of COL3A1. This
finding was confirmed in the skin from 4-week-old mice by
western blots, which revealed that there is significantly more
COL3A1 in the skin of Tsk2/þ mice compared with age- and
sex-matched WT littermates (Figure 4b and c). We propose
that the excess COL3A1 protein we observe by several
measures in Tsk2/þ mice is due to a trend for excess
production of Col3a1 mRNA (Figure 2a) rather than reduced
degradation of the Col3 protein. Because the PIIINP fragment
is removed from the majority of Col3 molecules before natural
Col3 turnover degradation takes place in the tissue, mature
COL3A1 from Tsk2 is identical to mature COL3A1 from WT
mice, and its natural degradation is unlikely to be affected by
any changes in PIIINP. These data show that there is an overall
Table 2. Progeny born from Col3a1-deficient, Col3a1-sufficient, and Tsk2/þ mice
(A)
Genotype and phenotype of progeny
Parents Tsk2/þ (tight skin) WT/WT (normal skin) Tsk2/Tsk2 (lethal)
Tsk2/þ Tsk2/þ 22 21 0
Col3a1þ /Col3a1 (normal skin) Col3a1þ /Col3a1þ (normal skin) Col3a1 /Col3a1 (moribund)
Col3a1 /þ Col3a1 /þ 16 13 3
(B)
Genotype and phenotype of progeny
Parents WT/Col3a1þ (normal skin) Tsk2/Col3a1þ (tight skin) WT/Col3a1 (normal skin) Tsk2/Col3a1
Tsk2/þ Col3a1 /þ 12 10 15 0
Abbreviations: Col3a1, collagen, type III, alpha 1; SNP, single-nucleotide polymorphism; Tsk, tight skin; WT, wild type.
All progenies were assessed for chromosome 1 markers (SNPs and microsatellites) that characterize the origin of the tested allele (Tsk2 or Col3a1).
(A, top) shows the number of mice born of each genotype and phenotype from Tsk2/þ  Tsk2/þ or Col3a1 /þ Col3a1 /þ parents.
(B, bottom) shows the number of mice born of each genotype and phenotype from Tsk2/þ Col3a1 /þ parents; note: there are no compound heterozygotes
(Tsk2/Col3a1 ) born from this mating.
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increased accumulation of mature COL3A1 protein in the
Tsk2/þ mice; in addition, at least half of the type III
procollagen and PIIINP trimers produced likely contain one
or more strands bearing the Tsk2 (C33S) mutation.
DISCUSSION
Sequencing of both expressed RNAs and the genomic region
in the Tsk2/þ interval, coupled with the genetic complemen-
tation study, prove that Tsk2/þ mice harbor a deleterious
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coding mutation in Col3a1, leading to an amino acid change
(C33S) in the N-terminal region of the protein (PIIINP). This
point mutation is consistent with those expected from ethylni-
trosourea-induced mutagenesis, which generates random sin-
gle-base-pair point mutations by direct alkylation of nucleic
acids. The most common mutations are AT-to-TA and AT-to-
GC changes (Noveroske et al., 2000; Cordes, 2005); all three
Tsk2-specific mutations identified here were T-to-A or T-to-C
mutations. The Tsk2/þ allele is expressed in a 1:1 ratio with
the WT by RNA-Seq indicating equal transcription and making
a duplication event unlikely.
Effects of the Tsk2 mutation include the following: (1)
accumulation of COL3A1 protein in vivo over time; (2)
induction and accumulation of COL1A1 protein in vivo and
in in vitro expression models; (3) a more lethal phenotype
compared with the homozygous genetic loss of Col3a1; and
(4) a more lethal compound heterozygous phenotype com-
pared with that of the homozygous gene KO. The latter two
characteristics indicate that COL3A1Tsk2 (C33S) has a domi-
nant prenatal lethal effect, although our in vitro complementa-
tion results suggest that the presence of COL3A1-C33S (or its
mRNA) is not lethal to skin fibroblasts per se. A major function
of the Col3a1 gene is promoting blood vessel development
(Liu et al., 1997), which likely led to the lethality observed in
the complementation experiment. In the Col3a1-KO, a few
mice are born with the homozygous deficiency, and these
mice die of rupture of the major blood vessels (Liu et al.,
1997). The possibility that Col3a1Tsk2 mutation could directly
induce a deleterious vascular phenotype in Tsk2/þ mice is
intriguing; it is notable that genes encoding vascular features
(Flt1 and Flt4, genes for vascular endothelial growth factor
receptors) are significantly upregulated in both Col3a1Tsk2-
transfected skin fibroblasts and in Tsk2/þ skin relative to WT
(Figure 3g). It is possible that a complete Col3a1 deficiency
could be compensated by other collagens, but the Col3a1Tsk2
mutation is a deleterious gain-of-function, and the deposition
of COL3A1-C33S may actively prevent other more benign
collagen alternatives from functioning in the vasculature.
Thus, our theory is that two doses of a damaging protein are
worse than no expression of a normal one.
To our knowledge, this is the first mutation in Col3a1 that
results in a gain-of-function phenotype instead of Ehlers–
Danlos-like syndromes that are due to loss-of-function or
antimorphic collagen-poor phenotypes. Ehlers–Danlos is a
group of connective tissue disorders characterized by highly
elastic, fragile but not fibrotic skin due to a defect in collagen
synthesis (Nishiyama et al., 2001). In addition, these patients
have a significant risk for aneurism. The Ehlers–Danlos
syndrome has been associated with 337 mutations in COL3A1
(http://www.le.ac.uk/ge/collagen/), as well as mutations on
COL1A1 and COL5A2. These mutations result in amino acid
substitutions in the C terminus of the protein, RNA splicing
alterations, deletions, or null alleles. Interestingly, in the
Ehlers–Danlos syndrome type IV (a very different disease than
that observed in Tsk2/þ mice), studies have shown that
patients bearing a mutated COL3A1 (compared with a null
COL3A1) develop more severe disease and succumb to
disease prematurely, whereas those with null COL3A1 were
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able to live a relatively normal life with limited disease
(Leistritz et al., 2011). Currently, all reported COL3A1
mutations result in decreased collagen protein secretion
leading to variably thinner skin and defects in the
vasculature that are observed in these patients. In contrast to
the mutations observed in Ehlers–Danlos, the Tsk2/þ mouse
mutation results in thickened skin with no apparent evidence
of aneurism. The mutation reported here occurs in the
N-terminal PIIINP fragment of the protein, rather than the
C-terminal region associated with Ehlers–Danlos.
The PIIINP molecule is a homotrimer with a molecular
weight of B42,000 daltons and comprises three domains: a
cysteine-rich globular domain (Col 1) containing 79 amino
acids with five intrachain disulfide bonds, a triple-helical
domain (Col 3) with 12 amino acids and three interchain
disulfide bonds, and a non-collagenous domain (Col 2)
comprising 39 amino acids ending with the N-telopeptide
that forms a triple helical structure (Bruckner et al., 1978). The
mutation in Col3a1Tsk2 substitutes a serine for the cysteine in
one of the five Col 1-domain cysteines involved in disulfide
bonds (Bruckner et al., 1978).
Features shared by Tsk2/þ mice and people with fibrotic
diseases (scleroderma, liver fibrosis, and kidney fibrosis)
include the dysregulation of PIIINP (Sondergaard et al.,
1997; Majewski et al., 1999; Abignano and Del Galdo,
2014; Del Galdo and Matucci-Cerinic, 2014; Quillinan
et al., 2014). The PIIINP fragment is a clinically validated
biomarker of liver fibrosis (Leroy et al., 2004; Rosenberg et al.,
2004) and scleroderma (Sondergaard et al., 1997; Majewski
et al., 1999), and it has been used as a surrogate marker of
fibrosis in clinical trials of potential SSc therapies (Majewski
et al., 1999; Denton et al., 2009). Our finding of a point
mutation in the protein that likely has a deleterious effect on
PIIINP function is consistent with these clinical results and the
fibrotic phenotype in the Tsk2/þ mouse.
Its high level in the sera of such patients may not merely be
a benign biomarker. Support for this hypothesis derives from
our in vitro complementation results showing that the pre-
sence of COL3A1-C33S is sufficient to upregulate the synthesis
and secretion of COL1A1, consistent with the increased
activity of the Col1a1 promoter and excess production of
COL1A1 in Tsk2/þ mice (Christner et al., 1998; Barisic-
Dujmovic et al., 2008). It is likely that higher levels of or
altered COL3A1 protein or PIIINP fragment also directly
influence the composition and size of COL1A1/A2- and
COL3A1-containing fibers, and that these features indirectly
upregulate transforming growth factor-b1 signaling, an
important mediator of collagen production. A previous
report from our laboratory has demonstrated increased
dermal elastic fibers and transforming growth factor-b1
accumulation in the skin of Tsk2/þ mice beginning at 2
weeks of age, lending further support to our hypothesis (Long
et al., 2014). In addition, our gene expression analyses show
that similar global impact of the Col3a1Tsk2 gene occurs both
in vitro and in vivo, and in both settings there are fundamental
changes in the ECM and in fibroblasts due to the presence of
this mutation. The hypothesis that Col3a1Tsk2 (or PIIINPTsk2)
directly causes dermal fibrosis and scleroderma-like charac-
teristics is attractive: it would likely be dominant within the
heterozygote, as collagen III is a homotrimeric triple helix
(Ramachandran and Kartha, 1955), and the gene product of
the mutant chromosome could be expected to contribute to
alteration of a majority of collagen helices even in the
presence of 50% normal collagen (Strachan and Read, 1999).
MATERIALS AND METHODS
All studies and procedures were approved by the Institutional Animal
Care and Use Committee at Drexel University College of Medicine
and conducted in accord with recommendations in the ‘‘Guide for
the Care and Use of Laboratory Animals’’ (Institute of Laboratory
Animal Resources, National Research Council, National Academy of
Sciences). Detailed methods are provided in the Supplementary
Materials online.
Animals
Tsk2/þ mice were serially backcrossed to the C57Bl/6J (B6)
background. Recombinant B6.Tsk2/þ mice were also bred to
B6.chr 1-A/J mice (Jackson Laboratory, Bar Harbor, ME) and the
resulting B6.Tsk2/þ F1 mice were backcrossed to B6.chr 1-A/J mice.
Wild-type littermates were used as controls.
DNA isolation from tail snips, microsatellite, and SNP typing
These were performed as in our previous publications (Bunce et al.,
1995; Butterfield et al., 1998). Specific locations of SNP polymorphisms
between B6 (which is very similar to 101/H) and A/J were determined
using Mouse Genome Informatics (www.informatics.jax.org) and
Mouse Phenome Database (http://phenome.jax.org/).
Complementation analysis
Tsk2/þ mice were crossed to Col3a1 /þ mice and their progeny
mated to verify that the SNP in Col3a1 is Tsk2. The resulting
generations of the cross were genotyped by PCR for Tsk2/þ using
microsatellites and primers specific to Col3a1 or the inserted
neomycin cassette (see Supplementary Material online).
In vitro assessment of fibrogenesis by COL3A1Tsk2
We constructed a plasmid harboring the Col3a1Tsk2 allele by introdu-
cing the Tsk2 T-to-A mutation into a wild-type Col3a1 clone (pCMV6-
Kan/Neo; OriGene, Rockville, MD). A Col3a1-KO line was transfected
with either plasmid as described (Artlett et al., 1998). Supernatants
were retained and cell lysates were harvested directly from the dish at
48 hours.
RNA isolation and real-time PCR
RNA was isolated from the skin or fibroblasts using a RNA isolation
kit from Clontech (Mountain View, CA), and cDNAs synthesized from
2.0mg of total RNA using an High Capacity cDNA Reverse Transcrip-
tion kit (Applied Biosystems, Foster City, CA). Relative quantification
of all products was measured using SYBR Green chemistry (Applied
Biosystems).
RNA sequencing
Total RNA was prepared from three WT and four Tsk2/þ mice skin
biopsies using the Qiagen RNeasy Fibrous Tissue Mini Kit (Qiagen
Sciences, Germantown, MD). RNA-seq sequencing libraries were
prepared for the seven samples using a NuGEN Ovation RNA-Seq
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System (NuGEN Technologies, San Carlos, CA). Libraries were
multiplexed and sequenced on an Illumina HiSeq 2000 platform to
obtain 16.7–50.9 million 50bp paired-end reads per sample. The raw
reads were aligned to the reference mouse genome (MM9 assembly)
using Tophat software with default parameters (Trapnell et al., 2009;
Trapnell et al., 2012). Supplementary Figure S1 online shows RNA-Seq
read coverage for three interval genes. RNA-seq data from this study are
available from NCBI Bioproject at accession number PRJNA262679.
454 Sequencing
Samples were captured and amplified as described in the Roche
Nimblegen sequence capture manual (version 1.0; Madison, WI).
Titanium general libraries were prepared from the captured DNAs
from two 101/H mice and two Tsk2/þ mice using 5,000ng of DNA.
Enriched captured fragments were sequenced as described in GS FLX
Titanium emPCR and Sequencing Protocols, October 2008. Sequence
capture array probes were designed by Roche Nimblegen using the
mouse genome sequence between 44,241,286 and 47,116,890 on
chromosome 1 of mouse genome (MM9). Multiplexed 454 sequenced
reads were assembled using Newbler v2.6 (454 Life Sciences,
Branford, CT) with scaffolding against the same chromosome region
that the probes were derived from.
DNA microarray hybridization and data analysis
This was performed as in our previous publications (Pendergrass
et al., 2012). RNA samples were amplified and labeled using the
Agilent Low Input Linear Amplification kit (Agilent Technologies,
Santa Clara, CA) and were hybridized against Universal Mouse
Reference (Strategene, La Jolla, CA) to Agilent Whole Mouse
Genome arrays (G4122F; Agilent Technologies) in a common
reference-based design. Microarrays were hybridized and washed in
accordance with the manufacturer’s protocols and scanned using a
dual laser GenePix 4000B scanner (Axon Instruments, Foster City,
CA). The pixel intensities of the acquired images were then quantified
using GenePix Pro 5.1 software (Axon Instruments). Raw microarray
data from this study are available from NCBI GEO at accession
number GSE61728.
Western blot analyses
Culture supernatants were collected or the skin was homogenized in
RIPA buffer (Sigma-Aldrich, St Louis, MO) using a glass homogeni-
zer. Total protein was measured with a Bradford assay (Sigma-
Aldrich), and western blots were performed as in our publications
(Sassi-Gaha et al., 2010). Antibodies used included goat anti-
COL3A1 (#sc-8781), goat anti-COL1A1 (#sc-28657) from Santa
Cruz Biotechnology, Santa Cruz, CA, rabbit anti-b-Actin (#4967,
Cell Signaling Technologies, Boston, MA), donkey anti-goat (#705-
035-003, Jackson ImmunoResearch Laboratories, West Grove, PA),
or goat anti-rabbit (#111-035-003, Jackson ImmunoResearch), and
signals were developed using SuperSignal West Dura ECL reagent
(Thermo Scientific, Rockford, IL). Band intensities were measured
using ImageQuant TL Software (GE Healthcare Life Sciences,
Pittsburgh, PA).
Reticular fiber staining
Reticular fibers were stained using the Chandler’s Precision Reticular
Fiber Stain kit (American Master*Tech, Lodi, CA) according to the
manufacturer’s protocol.
Statistics
A two-tailed Student t-test or a one-way analysis of variance was used
to determine statistical significance of collagen protein expression, as
noted.
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